Editorial

Osteoporosis: We Are Neglecting Our Own

Authors: Ronald C. Hamdy, MD, FRCP, FACP

Abstract

In the dawn of the twenty-first century, we claim with pride to practice evidence-based medicine, but when it comes to osteoporosis, what we practice is different from the available evidence. The evidence we have gathered about the disease, its implications and treatment, has not yet affected our practice. Osteoporosis is still largely neither diagnosed, nor treated.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. King AB, Saag KG, Burge RT, et al. Fracture reduction affects Medicare economics: impact of increased osteoporosis diagnosis and treatment. Osteop Int 2005;16:1545–1547.
 
2. Cummings SR, Melton LJ 3rd. Epidemiology and outcomes of osteoporotic fractures. Lancet2002;359:1761–1767.
 
3. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res1997;12:24–35.
 
4. Chrischilles EA, Butler CD, Davis CS, et al. A model of lifetime osteoporosis impact. Arch Intern Med1991;151:2026–2032.
 
5. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646–650.
 
6. Hamdy RC, Chesnut CH 3rd, Gass ML, et al. Review of treatment modalities for postmenopausal osteoporosis. South Med J 2005;98:1000–1014.
 
7. Schousboe JT, Ensrud KE, Nyman JA, Melton LJ 3rd, Kane RL. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc 2005;53:697–704.
 
8. McNearney TA, Shepherd AJ, Chhabra A, Goel N. Primary care house staff attitudes toward osteoporosis management. South Med J 2006;99:461–466.